| RBDTX | RCDTX | RBDTX / RCDTX | |
| Total Expense Ratio | 1.40 | 0.95 | 147% |
| Annual Report Gross Expense Ratio | 1.40 | 0.95 | 147% |
| Fund Existence | 19 years | 19 years | - |
| Gain YTD | 13.433 | 13.865 | 97% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 32.3B | 32.3B | 100% |
| Annual Yield % from dividends | 1.59 | 1.95 | 81% |
| Returns for 1 year | 8.39 | 8.86 | 95% |
| Returns for 3 years | 25.95 | 27.45 | 95% |
| Returns for 5 years | 14.51 | 16.73 | 87% |
| Returns for 10 years | 48.78 | 52.66 | 93% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SGDJ | 89.05 | 2.83 | +3.28% |
| Sprott Junior Gold Miners ETF | |||
| YGLD | 43.69 | 0.62 | +1.44% |
| Simplify Gold Strategy PLUS Income ETF | |||
| RQI | 11.39 | -0.01 | -0.09% |
| COHEN & STEERS QUALITY Income REALTY FUND | |||
| KEMX | 37.43 | -0.17 | -0.44% |
| KraneShares MSCI Em Mkts ex CHN ETF | |||
| BIS | 9.50 | -0.15 | -1.53% |
| ProShares UltraShort Nasdaq Biotech | |||